1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Thirumalai Chemicals Limited

Thirumalai Chemicals Limited

120.20
INR
-5.30
(-4.22%)
-12.94EPS
20.13BMarket Cap
Thirumalai Chemicals Limited
BSE:TIRUMALCHM
(Bombay Stock Exchange)

Recent

price

120.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
74.66
102.94
133.93
124.65
104.72
92.22
99.55
127.29
122.1
104.97
105.34
194.2
207.09
202.32
198.95
152.89
156.31
Revenue per Share
1.75
0.09
4.28
1.16
-1.34
3.14
6.9
16.65
11.09
2.26
11.49
27.47
8.77
-3.79
-4.5
-14.91
-12.94
Basic EPS, GAAP
-4.99
-4.94
0.56
10.73
12.91
9.53
8.2
2.14
3.98
3.6
15.61
39.3
5.29
23.15
-6.43
-11.61
- -
Free Cash Flow per Basic Share
0.58
- -
0.58
0.29
- -
1.69
- -
2.26
2.41
2.36
- -
2.18
2.5
1.5
1
- -
- -
Dividend per Share
11.75
15.05
19.43
21.01
18.86
29.96
38.89
55.96
65.23
62.33
78.39
105.97
116.41
111.95
112.87
129.7
- -
Book Value per Share
11.75
15.05
19.43
21.01
18.86
28.22
37.14
54.2
62.36
62.29
78.37
105.96
116.39
111.93
112.86
129.68
- -
Tangible Book Value per Share
102
102
102
102
102
102
102
102
102
102
102
102
102
102
102
113
117
Basic Weighted Avg Shares
7,644
10,540
13,713
12,762
10,723
9,442
10,193
13,033
12,502
10,748
10,786
19,884
21,203
20,715
20,370
17,219
18,321
Sales/Revenue/Turnover
6.73
4.92
8.28
4.68
3.53
8.5
12.24
20.4
13.71
3.7
15.91
19.48
6.17
-0.3
-0.2
-6.21
-3.8
Operating Margin (%)
154
226
229
230
178
251
359
306
364
441
495
566
557
632
611
884
897
Depreciation Expense
179
9
438
119
-137
322
707
1,704
1,136
232
1,177
2,812
898
-388
-461
-1,679
-1,516
Net Income, GAAP
29.79
54.63
32.04
20.21
- -
41.37
35.33
32.63
32.74
39.28
25.1
25.08
30.58
- -
- -
- -
- -
Effective Tax Rate (%)
2.35
0.09
3.19
0.93
-1.28
3.41
6.93
13.08
9.08
2.16
10.91
14.14
4.24
-1.87
-2.26
-9.75
-8.28
Profit Margin (%)
-841
229
533
330
-118
-241
421
1,937
1,314
1,981
2,721
4,758
1,870
1,050
350
-5,005
- -
Working Capital
326
1,425
1,074
595
388
236
117
500
784
1,840
1,582
1,373
2,142
8,938
14,746
16,454
- -
LT Debt
1,311
1,541
1,990
2,151
1,931
3,068
3,982
5,730
6,679
6,381
8,029
10,850
11,919
11,462
11,557
15,636
- -
Total Equity
5.14
0.28
10.19
2.7
- -
9.1
18.88
33.22
16.93
3.36
14.22
25.87
6.19
- -
- -
- -
- -
Return on Invested Capital (%)
5.57
0.28
10.19
9.82
- -
11.55
18.82
32.24
16.93
3.95
14.39
26.29
7.31
- -
- -
- -
- -
Return on Capital (%)
17.33
0.67
24.82
5.73
-6.72
12.86
20.05
35.1
18.31
3.55
16.33
29.79
7.89
-3.32
-4.01
-12.35
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
5,293
- -
LT Borrowings
- -
15,658
- -
LT Finance Leases
- -
795
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
121
121
121
Market Capitalization
28,450
19,897
20,132

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
7,968
- -
Cash, Cash Equivalents & STI
- -
702
- -
Accounts Receivable, Net
- -
1,970
- -
Inventories
- -
1,847
- -
Total Current Liabilities
- -
12,973
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
5,293
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.89%
15.46%
35.3%
Free Cash Flow
69.58%
74.77%
98.44%
Net Income, GAAP
76.68%
42.16%
264.23%
Sales/Revenue/Turnover
8.96%
14.31%
-15.47%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
5,547
5,251
4,467
5,231
20,370
2026
4,501
4,454
4,159
4,243
17,219
2027
5,467
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.5
0.48
-4.1
-1.37
-4.5
2026
-5.86
-3.07
-3.92
-2.32
-14.91
2027
-3.62
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
Dow Inc. (NYSE:DOW)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Business
Thirumalai Chemicals Limited engages primarily in the manufacture and sale of specialty and intermediate chemicals. Its core products include phthalic anhydride, maleic anhydride, malic acid, and fumaric acid, along with food ingredients and specialty food acids. The company also produces fine chemicals and phthalate esters used as downstream derivatives. It operates through subsidiaries including TCL Intermediates Private Limited and Optimistic Organic Sdn. Bhd. in Malaysia, and TCL Specialties LLC in the USA. Founded in 1972 and headquartered in Ranipet, Tamil Nadu, India, Thirumalai Chemicals serves domestic and international markets with diverse applications in polymers, paints, coatings, cosmetics, personal care, and food industries. Recently, Thirumalai Chemicals has expanded its product portfolio by commencing commercial production of fumaric acid from a greenfield plant in Dahej, expected to add incremental quarterly revenue. The company is advancing a greenfield food ingredients and fine chemicals plant in the USA through its wholly owned subsidiary TCL Specialties LLC, with Phase I construction progressing and final pre-commissioning tests expected soon. Additionally, Thirumalai Chemicals acquired a maleic anhydride plant in Malaysia via its subsidiary, broadening its manufacturing footprint overseas. Strategic amendments to its Articles of Association were approved in 2025, and the company is actively pursuing fund raising initiatives and preferential equity issuance to support growth and expansion plans. Thirumalai Chemicals operates primarily in specialty and functional chemicals segments with key markets spanning Asia, North America, and other international regions. Its product applications cater to specialty polymers, food additives, paint and coatings, cosmetics and personal care, and industrial intermediates. The company’s strategy centers on expanding its global manufacturing presence while diversifying into related chemicals and value-added downstream derivatives to capture broader market segments and enhance revenue streams.